Invention Grant
- Patent Title: Methods of selecting T cell receptors using affinity oligonucleotide conjugates
-
Application No.: US15405301Application Date: 2017-01-12
-
Publication No.: US10393743B2Publication Date: 2019-08-27
- Inventor: Francois Vigneault , Adrian Wrangham Briggs , Stephen J. Goldfless , Brian J. Belmont
- Applicant: AbVitro LLC
- Applicant Address: US WA Seattle
- Assignee: AbVitro LLC
- Current Assignee: AbVitro LLC
- Current Assignee Address: US WA Seattle
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
- Main IPC: C12P19/34
- IPC: C12P19/34 ; G01N33/569 ; C12Q1/6804 ; C12Q1/6869 ; C12N15/10 ; C12Q1/6881 ; G01N33/68

Abstract:
Provided herein are methods and compositions for single cell characterization using affinity-oligonucleotide conjugates, including tetramer-oligonucleotide conjugates (e.g., pMHC-oligonucleotide). In some aspects, such methods may comprise the steps of: forming a vessel comprising an affinity-oligonucleotide conjugate and a T cell; attaching a vessel barcoded polynucleotide or complement thereof to: (a) an oligonucleotide portion of a pMHC-oligonucleotide conjugate, and (b) a T cell receptor (TCR) polynucleotide originating from the T cell; and sequencing the oligonucleotide portion or a complement thereof and the TCR polynucleotide or a complement thereof. Additional methods provided herein include determining the binding affinity of a T cell receptor (TCR) to a pMHC-oligonucleotide. Compositions of the present invention encompass a plurality of vessels, wherein a vessel of the plurality of vessels may comprise a single T cell; and a vessel barcoded polynucleotide, wherein the vessel may further comprise a pMHC-oligonucleotide conjugate.
Public/Granted literature
- US20170268056A1 AFFINITY-OLIGONUCLEOTIDE CONJUGATES AND USES THEREOF Public/Granted day:2017-09-21
Information query